RITA-1 randomized 1,011 patients with CHD (45% single-vessel, 55% multivessel, 62 patients (6.1%) with T2DM) and showed a trend toward lower mortality in the PTCA than in the CABG group with no difference in total health-service costs over 5 years between the 2 strategies [ 28 ].
← all excerpts
Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
1
—
—